Welcome to Clavis Pharma

The Key to Improved Cancer Therapy

Clavis Pharma ASA is a clinical stage oncology focused pharmaceutical company based in Oslo, Norway, with a portfolio of novel anti-cancer drugs in development. These potential breakthrough products are New Chemical Entities (NCEs) made using Clavis Pharma's Lipid Vector Technology (LVT) chemistry to introduce new properties to already established, commercially successful drugs. Clavis Pharma intends to commercialise its products through strategic alliances and partnerships with experienced oncology businesses and, where and when commercially appropriate, by establishing its own sales and marketing capabilities.